Gary PalmerBuy
ASND · Transaction Aug 6, 2018 · Filed Sep 29, 2018 · $1,001 to $15,000
NASDAQ NMS - GLOBAL MARKET · ASND
+3.39% · +$7.57 · Vol 1.2M
Market closed · last close 4:00 PM ET · price as of 17:19:50 ET
Ascendis Pharma A/S
Biotechnology
$230.70
Follow $ASND
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $ASND by emailVeridion Score
BETAMEDIUM CONF · 6 of 6 factors measuredThu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET · ASND
MethodologyASND
Ascendis Pharma A/S
Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Lower range
Highest qualified requires a score of at least 75 and high confidence, including full factor coverage. Upper range can hold a higher score with lower confidence.
Composite intelligence score across six company factor categories. Missing inputs are excluded from the active factor subset.
32/ 100
Veridion Score
Lower range · MEDIUM confidence · 6 of 6 factors measured
Sovereign · $25/mo
See why this score moved.
- · Factor breakdown with raw signals
- · Day-over-day delta + driver
- · Factor coverage readout
- · Valuation · hype · market flow
- · Pro Chart event markers
- · Score history + alerts
Start Sovereign · $25/mo →
Cancel anytime · or Reserve · $79/mo
Confidence: MEDIUM · 6 of 6 factors measured · Thu Sep 24 · market closed · Markets closed · resumes Fri 9:30 ET
Veridion Score History · 90D
Loading score history
AI Analysis
SovereignWhy is ASND moving today?
Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Ascendis Pharma A/S
BiotechnologyListed since
2026
Employees
1K
Country
DK
Ascendis Pharma AS is a biopharmaceutical company that applies its TransCon technology platform to make a meaningful difference for patients. The firm's product pipeline includes Endocrinology and Oncology, which includes TransCon PTH, TransCon CNP, and others. It operates in the United States, Europe, and the rest of the world and derives the majority of its revenue from the United States.
Key statistics
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
Open
$223.00
Day high
$231.13
Day low
$220.23
Previous close
$223.13
52W high
$277.18
-16.77% from high
52W low
$189.74
47% of range
Market cap
$14.7B
P/E
16.50×
EPS
$11.03
Beta
0.41
Shares out
65.8M
Volume
1.2M
1.55× rel vol
Avg volume
752.2K
VWAP
$227.94
Price history computed in-house
1W
-2.54%
1M
-7.81%
3M
-11.52%
1Y
+21.59%
YTD
+8.19%
SMA 50 $252.01 · below
SMA 200 $234.98 · below
52W position 47%
ASND overview
Related filings and maps
Public disclosures
Congress activity in ASND
Official filing ↗
Ascendis Pharma A/S - American Depositary Shares · Transaction Jul 12, 2018 · Filed Sep 29, 2018 · $1,001 to $15,000
Federal contracts
ASND contract awards, year to date.
Public federal awards linked to this ticker.
Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for ASND in this window.
Lobbying spend
ASND lobbying filings, year to date.
Registered lobbying filings matched to Ascendis Pharma A/S.
Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for ASND in this window.
Analyst ratings
Sovereign unlock shows live analyst consensus for ASND.
Options
Sovereign unlock shows live options positioning for ASND.